ID   LICR-LON-Fib-75
AC   CVCL_XH45
SY   LICR-LON-Fib 75; LICR-LON-FIB75; LICR-LOND Fib 75; LICR-LOND-Fib 75; Fib-75-H; Fib-75; FIB 75
DR   Wikidata; Q95982181
RX   Patent=US5003046;
RX   PubMed=3894386;
RX   PubMed=7222219;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-211.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human 19 kDa cell surface glycoprotein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 5
//
RX   Patent=US5003046;
RA   Neville A.M., Foster C.S., Edwards P.A.W., McIlhinney R.A.J.;
RT   "Monoclonal antibody producing hybridoma and corresponding antibody
RT   specific for human breast fibroblast tumor antigen.";
RL   Patent number US5003046, 26-Mar-1991.
//
RX   PubMed=3894386; DOI=10.1242/jcs.73.1.321;
RA   Edwards P.A.W., Skilton R.A., Payne A.W.R., Ormerod M.G.;
RT   "Antigenic heterogeneity of breast cell lines detected by monoclonal
RT   antibodies and its relationship with the cell cycle.";
RL   J. Cell Sci. 73:321-333(1985).
//
RX   PubMed=7222219;
RA   Edwards P.A.W., Foster C.S., McIlhinney R.A.J.;
RT   "Monoclonal antibodies to teratomas and breast.";
RL   Transplant. Proc. 12:398-402(1980).
//